Hanns–Ulrich Marschall

Research interests

Publications

• Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

  Cell Metabolism · 2016 · https://doi.org/10.1016/j.cmet.2016.05.005

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509840

• Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist

  Cell Metabolism · 2013 · https://doi.org/10.1016/j.cmet.2013.01.003

• Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

  Gastroenterology · 2013 · https://doi.org/10.1053/j.gastro.2013.05.042

• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  Transplantation · 2006 · https://doi.org/10.1097/01.tp.0000214462.63943.14

Current projects

No projects listed.